Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 20, Issue -, Pages 14-23Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2014.10.009
Keywords
-
Categories
Funding
- Fondation pour la Recherche Medicale ('Equipe FRM') [DEQ2000326520]
- French government under the program Investissements d'Avenir' [ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02 PSL]
Ask authors/readers for more resources
N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels that are essential mediators of excitatory neurotransmission and synaptic plasticity. NMDARs are also implicated in a plethora of neuropathological conditions thus receiving strong interest as potential therapeutic targets. Recent years have witnessed major progress in our understanding of the structure and pharmacology of NMDARs with the decoding of the first full-length receptor crystal structures and the discovery of allosteric modulators acting at novel binding sites and with unique patterns of subunit selectivity. Here we review the properties and structural mechanisms of various allosteric modulators that target NMDARs, emphasizing the newly identified compounds. The expanding pharmacology of NMDARs should help delineate the roles of various NMDAR subtypes in brain function, with potential for drug development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available